Lisbeth W. Roy, D.O., P.A. – Trademark Portfolio
Entity Type: 99
Lisbeth W. Roy, D.O., P.A. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PROSTAGEN. The owner is based in Boca Raton, FL.
Suite 260W
2300 Glades Road
Boca Raton, FL 33431
Showing of trademarks Trademarks
Trademark Classifications
Lisbeth W. Roy, D.O., P.A.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Lisbeth W. Roy, D.O., P.A. have?
Lisbeth W. Roy, D.O., P.A. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.
What trademark classes does Lisbeth W. Roy, D.O., P.A. file in?
Lisbeth W. Roy, D.O., P.A. files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 16 (Paper Goods), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Lisbeth W. Roy, D.O., P.A.'s most well-known trademarks?
Lisbeth W. Roy, D.O., P.A.'s registered trademark portfolio includes well-known marks such as PROSTAGEN. These are among 1 currently registered trademark in the portfolio.
What is Lisbeth W. Roy, D.O., P.A.'s trademark registration success rate?
Lisbeth W. Roy, D.O., P.A. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.